Dole Q1 2026 Earnings EPS Misses Estimates Revenue Not Disclosed SKIN Q1 2026 Earnings EPS Surpasses Estimates Stock Gains 421 NATR Q1 2026 Earnings Strong EPS Surprise Amid Quiet Revenue Disclosures Amphastar Pharmaceuticals AMPH Q1 2026 Earnings EPS Misses Estimates by Over 40 Yet Stock Rises SherwinWilliams SHW Q1 2026 Earnings Solid EPS Beat Amidst Mixed Demand Signals GameSquare Holdings Q1 2026 Earnings EPS Beat Driven by Cost Discipline Amid Revenue Uncertainty